BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carbonaro TM, Gatch MB. Neuropharmacology of N,N-dimethyltryptamine. Brain Res Bull 2016;126:74-88. [PMID: 27126737 DOI: 10.1016/j.brainresbull.2016.04.016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Lima Bezerra JJ, Vieira Pinheiro AA, Barbosa Lucena R. Phytochemistry and teratogenic potential of Mimosa tenuiflora (willd.) poir. (Fabaceae) in ruminants: A systematic review. Toxicon 2021;195:78-85. [PMID: 33727031 DOI: 10.1016/j.toxicon.2021.03.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hassan Z, Bosch OG, Singh D, Narayanan S, Kasinather BV, Seifritz E, Kornhuber J, Quednow BB, Müller CP. Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Front Psychiatry 2017;8:152. [PMID: 28868040 DOI: 10.3389/fpsyt.2017.00152] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
3 Müller TE, Fontana BD, Bertoncello KT, Franscescon F, Mezzomo NJ, Canzian J, Stefanello FV, Parker MO, Gerlai R, Rosemberg DB. Understanding the neurobiological effects of drug abuse: Lessons from zebrafish models. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2020;100:109873. [DOI: 10.1016/j.pnpbp.2020.109873] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
4 Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Mota-Rolim SA, Osório FL, Sanches R, Dos Santos RG, Tófoli LF, de Oliveira Silveira G, Yonamine M, Riba J, Santos FR, Silva-Junior AA, Alchieri JC, Galvão-Coelho NL, Lobão-Soares B, Hallak JEC, Arcoverde E, Maia-de-Oliveira JP, Araújo DB. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med 2019;49:655-63. [PMID: 29903051 DOI: 10.1017/S0033291718001356] [Cited by in Crossref: 151] [Cited by in F6Publishing: 70] [Article Influence: 37.8] [Reference Citation Analysis]
5 Ma F, Yang L, Sun Z, Chen J, Rui X, Glass Z, Xu Q. Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection. Sci Adv 2020;6:eabb4429. [PMID: 32832671 DOI: 10.1126/sciadv.abb4429] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
6 Rodrigues AV, Almeida FJ, Vieira-coelho MA. Dimethyltryptamine: Endogenous Role and Therapeutic Potential. Journal of Psychoactive Drugs 2019;51:299-310. [DOI: 10.1080/02791072.2019.1602291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Lima da Cruz RV, Moulin TC, Petiz LL, Leão RN. Corrigendum: A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus. Front Mol Neurosci 2019;12:79. [PMID: 31019450 DOI: 10.3389/fnmol.2019.00079] [Reference Citation Analysis]
8 Liu M, Yang H, Hu J, Shen B, Xiang P, Qiang H, Deng H, Yu Z, Shi Y. Analysis of 28 hair samples from users of the hallucinogenic beverage ayahuasca. Forensic Sci Int 2021;323:110790. [PMID: 33894686 DOI: 10.1016/j.forsciint.2021.110790] [Reference Citation Analysis]
9 Colaço CS, Alves SS, Nolli LM, Pinheiro WO, de Oliveira DGR, Santos BWL, Pic-Taylor A, Mortari MR, Caldas ED. Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats. Metab Brain Dis 2020;35:739-51. [PMID: 32103409 DOI: 10.1007/s11011-020-00547-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Davis AK, Clifton JM, Weaver EG, Hurwitz ES, Johnson MW, Griffiths RR. Survey of entity encounter experiences occasioned by inhaled N,N -dimethyltryptamine: Phenomenology, interpretation, and enduring effects. J Psychopharmacol 2020;34:1008-20. [DOI: 10.1177/0269881120916143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
11 Diab H, Malcolm B. Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT). J Psychoactive Drugs 2021;53:140-5. [PMID: 33242285 DOI: 10.1080/02791072.2020.1847366] [Reference Citation Analysis]
12 Gatch MB, Dolan SB, Forster MJ. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents. Behav Pharmacol 2017;28:375-85. [PMID: 28537942 DOI: 10.1097/FBP.0000000000000309] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
13 Hamill J, Hallak J, Dursun SM, Baker G. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness. Curr Neuropharmacol 2019;17:108-28. [PMID: 29366418 DOI: 10.2174/1570159X16666180125095902] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 10.7] [Reference Citation Analysis]
14 de Vos CMH, Mason NL, Kuypers KPC. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. Front Psychiatry 2021;12:724606. [PMID: 34566723 DOI: 10.3389/fpsyt.2021.724606] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Gerwe H, He F, Pottie E, Stove C, Decker M. Die Erhellung des “Bewusstseinsmoleküls”: Photomodulation des 5‐HT 2A Rezeptors durch ein licht‐steuerbares N,N‐Dimethyltryptamin‐Derivat. Angewandte Chemie. [DOI: 10.1002/ange.202203034] [Reference Citation Analysis]
16 Brito-da-Costa AM, Dias-da-Silva D, Gomes NGM, Dinis-Oliveira RJ, Madureira-Carvalho Á. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact. Pharmaceuticals (Basel) 2020;13:E334. [PMID: 33114119 DOI: 10.3390/ph13110334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kubicskó K, Farkas Ö. Quantum chemical (QM:MM) investigation of the mechanism of enzymatic reaction of tryptamine and N,N-dimethyltryptamine with monoamine oxidase A. Org Biomol Chem 2020;18:9660-74. [PMID: 33215182 DOI: 10.1039/d0ob01118e] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Hodge AT, Sukpraprut-braaten S, Narlesky M, Strayhan RC. The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review. Journal of Psychoactive Drugs. [DOI: 10.1080/02791072.2022.2044096] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lobao-Soares B, Eduardo-da-Silva P, Amarilha H, Pinheiro-da-Silva J, Silva PF, Luchiari AC. It's Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish. Front Behav Neurosci 2018;12:190. [PMID: 30210319 DOI: 10.3389/fnbeh.2018.00190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Cameron LP, Olson DE. Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT). ACS Chem Neurosci 2018;9:2344-57. [PMID: 30036036 DOI: 10.1021/acschemneuro.8b00101] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
21 Barker SA. N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function. Front Neurosci 2018;12:536. [PMID: 30127713 DOI: 10.3389/fnins.2018.00536] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
22 Ohshima Y, Kono N, Yokota Y, Watanabe S, Sasaki I, Ishioka NS, Sakashita T, Arakawa K. Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta-211At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing. Theranostics 2019;9:1538-49. [PMID: 31037122 DOI: 10.7150/thno.30353] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 James E, Keppler J, L Robertshaw T, Sessa B. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Hum Psychopharmacol 2022;37:e2835. [PMID: 35175662 DOI: 10.1002/hup.2835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 da Silva MG, Daros GC, de Bitencourt RM. Anti-inflammatory activity of ayahuasca: therapeutical implications in neurological and psychiatric diseases. Behav Brain Res 2021;400:113003. [PMID: 33166569 DOI: 10.1016/j.bbr.2020.113003] [Reference Citation Analysis]
25 Müller CP, Hassan Z. The evaluation of new psychoactive drugs. Brain Res Bull 2016;126:1-2. [PMID: 27235862 DOI: 10.1016/j.brainresbull.2016.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Borbély E, Varga V, Szögi T, Schuster I, Bozsó Z, Penke B, Fülöp L. Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ1-42-Injected, Wild-Type Mouse Model of AD. Int J Mol Sci 2022;23:2514. [PMID: 35269657 DOI: 10.3390/ijms23052514] [Reference Citation Analysis]
27 Elman I, Pustilnik A, Borsook D. Beating Pain with Psychedelics: Matter over Mind? Neurosci Biobehav Rev 2021:S0149-7634(21)00553-4. [PMID: 34922987 DOI: 10.1016/j.neubiorev.2021.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 da Motta LG, de Morais JA, Tavares ACA, Vianna LMS, Mortari MR, Amorim RFB, Carvalho RR, Paumgartten FJR, Pic-taylor A, Caldas ED. Maternal and developmental toxicity of the hallucinogenic plant-based beverage ayahuasca in rats. Reproductive Toxicology 2018;77:143-53. [DOI: 10.1016/j.reprotox.2018.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Lawrence DW, Carhart-Harris R, Griffiths R, Timmermann C. Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience. Sci Rep 2022;12:8562. [PMID: 35610230 DOI: 10.1038/s41598-022-11999-8] [Reference Citation Analysis]
30 Gainetdinov RR, Hoener MC, Berry MD. Trace Amines and Their Receptors.Pharmacol Rev. 2018;70:549-620. [PMID: 29941461 DOI: 10.1124/pr.117.015305] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 24.5] [Reference Citation Analysis]
31 Cameron LP, Benson CJ, DeFelice BC, Fiehn O, Olson DE. Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents. ACS Chem Neurosci 2019;10:3261-70. [PMID: 30829033 DOI: 10.1021/acschemneuro.8b00692] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 17.7] [Reference Citation Analysis]
32 Almeida CAF, Pereira-Junior AA, Rangel JG, Pereira BP, Costa KCM, Bruno V, Silveira GO, Ceron CS, Yonamine M, Camarini R, Garcia RCT, Marcourakis T, Torres LH. Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice. Behav Brain Res 2022;416:113546. [PMID: 34437939 DOI: 10.1016/j.bbr.2021.113546] [Reference Citation Analysis]
33 Barker SA. Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT. Psychopharmacology (Berl) 2022. [PMID: 35064294 DOI: 10.1007/s00213-022-06065-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Germann CB. 5-Methoxy-N,N-dimethyltryptamine: An Ego-Dissolving Endogenous Neurochemical Catalyst of Creativity. Act Nerv Super 2019;61:170-216. [DOI: 10.1007/s41470-019-00063-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Vorobyeva N, Kozlova AA. Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders. Front Pharmacol 2022;13:927984. [DOI: 10.3389/fphar.2022.927984] [Reference Citation Analysis]
36 Aakerøy R, Brede WR, Stølen SB, Krabseth HM, Michelsen LS, Andreassen TN, Ader T, Frost J, Slettom G, Steihaug OM, Slørdal L. Severe Neurological Sequelae after a Recreational Dose of LSD. J Anal Toxicol 2021;45:e1-3. [PMID: 33031536 DOI: 10.1093/jat/bkaa145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Glavonic E, Mitic M, Adzic M. Hallucinogenic drugs and their potential for treating fear-related disorders: Through the lens of fear extinction. J Neurosci Res 2022. [PMID: 35165930 DOI: 10.1002/jnr.25017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Schmeda-hirschmann G, Gomez CV, Rojas de Arias A, Burgos-edwards A, Alfonso J, Rolon M, Brusquetti F, Netto F, Urra FA, Cárdenas C. The Paraguayan Rhinella toad venom: Implications in the traditional medicine and proliferation of breast cancer cells. Journal of Ethnopharmacology 2017;199:106-18. [DOI: 10.1016/j.jep.2017.01.047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
39 Zhong S, Jeong JH, Huang C, Chen X, Dickinson SI, Dhillon J, Yang L, Luo JL. Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer. J Exp Clin Cancer Res 2021;40:307. [PMID: 34587977 DOI: 10.1186/s13046-021-02109-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Vallersnes OM, Persett PS, Øiestad EL, Karinen R, Heyerdahl F, Hovda KE. Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway. Clinical Toxicology 2017;55:636-44. [DOI: 10.1080/15563650.2017.1312002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
41 Shomrat T, Nesher N. Updated View on the Relation of the Pineal Gland to Autism Spectrum Disorders. Front Endocrinol (Lausanne) 2019;10:37. [PMID: 30804889 DOI: 10.3389/fendo.2019.00037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
42 Contreras N, Alvíz-amador A, Manzur-villalobos I. In silico study of dimethyltryptamine analogues against 5-HT1B receptor: Molecular docking, dynamic simulations and ADMET prediction. J Herbmed Pharmacol 2022;11:204-12. [DOI: 10.34172/jhp.2022.25] [Reference Citation Analysis]
43 de Almeida RN, Galvão ACM, da Silva FS, Silva EADS, Palhano-Fontes F, Maia-de-Oliveira JP, de Araújo LB, Lobão-Soares B, Galvão-Coelho NL. Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial. Front Psychol 2019;10:1234. [PMID: 31231276 DOI: 10.3389/fpsyg.2019.01234] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 10.7] [Reference Citation Analysis]
44 Gómez-Sousa M, Jiménez-Garrido DF, Ona G, Dos Santos RG, Hallak JEC, Alcázar-Córcoles MÁ, Bouso JC. Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series. J Clin Psychopharmacol 2021;41:163-71. [PMID: 33606432 DOI: 10.1097/JCP.0000000000001343] [Reference Citation Analysis]
45 Jiménez JH, Bouso JC. Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate. J Psychopharmacol 2022;:2698811221104054. [PMID: 35695604 DOI: 10.1177/02698811221104054] [Reference Citation Analysis]
46 [DOI: 10.1101/254268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Molecules 2022;27:2520. [DOI: 10.3390/molecules27082520] [Reference Citation Analysis]
48 Jamieson CS, Misa J, Tang Y, Billingsley JM. Biosynthesis and synthetic biology of psychoactive natural products. Chem Soc Rev 2021;50:6950-7008. [PMID: 33908526 DOI: 10.1039/d1cs00065a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
49 Latorre JI, Vellisca MY. Post-traumatic stress disorder, suggestibility, and dissociation related to alleged alien abductions. Explore (NY) 2021:S1550-8307(21)00218-4. [PMID: 34756534 DOI: 10.1016/j.explore.2021.10.003] [Reference Citation Analysis]
50 Ona G, Troncoso S. Long-lasting analgesic effect of the psychedelic drug changa : A case report. Journal of Psychedelic Studies 2019;3:7-13. [DOI: 10.1556/2054.2019.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
51 Szabó Í, Varga VÉ, Dvorácskó S, Farkas AE, Körmöczi T, Berkecz R, Kecskés S, Menyhárt Á, Frank R, Hantosi D, Cozzi NV, Frecska E, Tömböly C, Krizbai IA, Bari F, Farkas E. N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain. Neuropharmacology 2021;192:108612. [PMID: 34023338 DOI: 10.1016/j.neuropharm.2021.108612] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Durante Í, Dos Santos RG, Bouso JC, Hallak JE. Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects. Braz J Psychiatry 2021;43:362-9. [PMID: 33146343 DOI: 10.1590/1516-4446-2020-0913] [Reference Citation Analysis]
53 McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM. Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses. Neurosci Biobehav Rev 2022;138:104689. [PMID: 35588933 DOI: 10.1016/j.neubiorev.2022.104689] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Lawrence DW. Heart rate (HR) and heart rate variability (HRV) response to inhaled N, N-dimethyltryptamine (N, N-DMT): A case report. JPS 2022. [DOI: 10.1556/2054.2022.00178] [Reference Citation Analysis]
55 Lima da Cruz RV, Moulin TC, Petiz LL, Leão RN. A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus. Front Mol Neurosci 2018;11:312. [PMID: 30233313 DOI: 10.3389/fnmol.2018.00312] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
56 Abiero A, Ryu IS, Botanas CJ, Custodio RJP, Sayson LV, Kim M, Lee HJ, Kim HJ, Seo JW, Cho MC, Lee KW, Yoo SY, Jang CG, Lee YS, Cheong JH. Four Novel Synthetic Tryptamine Analogs Induce Head-Twitch Responses and Increase 5-HTR2a in the Prefrontal Cortex in Mice. Biomol Ther (Seoul) 2019;:83-91. [PMID: 31230432 DOI: 10.4062/biomolther.2019.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Lansky ES. Novel harmala-ocudelic tuning (HOT) for ocular disorders. Med Hypotheses 2020;143:109834. [PMID: 32498006 DOI: 10.1016/j.mehy.2020.109834] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Berlowitz I, Egger K, Cumming P. Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca. Front Pharmacol 2022;13:886408. [DOI: 10.3389/fphar.2022.886408] [Reference Citation Analysis]
59 Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. Molecules 2021;26:2451. [PMID: 33922330 DOI: 10.3390/molecules26092451] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
60 Lin HY, Chang TC, Chang ST. A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa. J Tradit Complement Med 2018;8:443-50. [PMID: 30302324 DOI: 10.1016/j.jtcme.2018.05.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
61 Eller S, Borges GR, Ossanes DS, Birk L, Scheid C, Yonamine M, Grossi P, Merib JO, Oliveira TF. A rapid analytical strategy for the determination of ayahuasca alkaloids in non-ritualistic approaches by UHPLC-MS/MS. Forensic Sci Int 2020;312:110298. [PMID: 32387868 DOI: 10.1016/j.forsciint.2020.110298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]